These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27206758)

  • 1. Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis.
    Lee HC; Thng TG; Goh CL
    J Am Acad Dermatol; 2016 Aug; 75(2):385-92. PubMed ID: 27206758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of oral tranexamic acid for vitiligo patients with melasma.
    Chiang PH; Lin YJ; Chiu YC; Chung WH; Ku CL; Ng CY
    Dermatol Ther; 2021 Sep; 34(5):e15047. PubMed ID: 34190390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of melasma with oral administration of tranexamic acid.
    Wu S; Shi H; Wu H; Yan S; Guo J; Sun Y; Pan L
    Aesthetic Plast Surg; 2012 Aug; 36(4):964-70. PubMed ID: 22552446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral tranexamic acid on erythema index in patients with melasma.
    Nguyen J; Rajgopal Bala H; Ross A; Wong CC; Paul E; Rodrigues M
    Australas J Dermatol; 2021 May; 62(2):206-209. PubMed ID: 33125702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of the combination of tranexamic acid injection and electro-optical synergy (ELOS) versus tranexamic acid injection alone in the treatment of melasma.
    Wang Y; Tang L; Duan J; Wang L; Ye F
    Lasers Med Sci; 2023 Aug; 38(1):179. PubMed ID: 37552377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Efficacy of Tranexamic Acid Solution 5% in the Treatment of Melasma in Patients of South Asian Descent.
    Akhtar N; Shah RR; Waqas N; Jasti S; Sharif S; Shah A; Abbasi HH; Rao B
    Cutis; 2023 Oct; 112(4):187-191.E4. PubMed ID: 37988305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
    Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
    J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
    Taraz M; Niknam S; Ehsani AH
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
    Kim HJ; Moon SH; Cho SH; Lee JD; Kim HS
    Acta Derm Venereol; 2017 Jul; 97(7):776-781. PubMed ID: 28374042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
    Badran AY; Ali AU; Gomaa AS
    Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature.
    Perper M; Eber AE; Fayne R; Verne SH; Magno RJ; Cervantes J; ALharbi M; ALOmair I; Alfuraih A; Nouri K
    Am J Clin Dermatol; 2017 Jun; 18(3):373-381. PubMed ID: 28283893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment.
    Polat Y; Saraç G
    Dermatol Ther; 2022 Jul; 35(7):e15499. PubMed ID: 35395121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
    Zhu CY; Li Y; Sun QN; Takada A; Kawada A
    Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral tranexamic acid for the treatment of melasma.
    Ali FR
    Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.